Indication Creep in Transcatheter Aortic Valve Implantation-Data or Desire?

Article Cardiac & Cardiovascular Systems

Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk

Daniel O'Hair et al.

Summary: This study aimed to evaluate the 5-year incidence and clinical outcomes of hemodynamic structural valve deterioration (SVD) in patients undergoing self-expanding transcatheter aortic valve implantation (TAVI) or surgery. The results showed a lower rate of SVD in the TAVI group and its association with worse clinical outcomes.

JAMA CARDIOLOGY (2023)

Add to Collection

Letter Cardiac & Cardiovascular Systems

National Trends in TAVR and SAVR for Patients With Severe Isolated Aortic Stenosis

Toishi Sharma et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve Stenosis

John K. Forrest et al.

Summary: The study aimed to evaluate the safety, efficacy, and 30-day outcomes of transcatheter aortic valve replacement in low-risk patients with bicuspid aortic valve stenosis. The results showed favorable 30-day outcomes, with low rates of death and stroke, and a high device success rate.

JAMA CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis Outside Randomized Trials

Alberto Alperi et al.

Summary: In a study evaluating low-risk patients with severe aortic stenosis undergoing SAVR, close to half of the patients had major criteria not evaluated in TAVR versus SAVR trials. Clinical outcomes were better than or similar to those predicted by surgical scores in most groups, except for patients requiring CMTV intervention.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement

Troels Hojsgaard Jorgensen et al.

Summary: In a study comparing clinical outcomes and valve durability after 8 years of follow-up in patients with symptomatic severe aortic valve stenosis at low surgical risk treated with either transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR), no significant differences were found in the risk for all-cause mortality, stroke, or myocardial infarction, as well as the risk of bioprosthetic valve failure between the two groups.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement

Troels Hojsgaard Jorgensen et al.

Summary: In patients with severe aortic valve stenosis at low surgical risk randomized to TAVI or SAVR, there were no significant differences in the risk for all-cause mortality, stroke, or myocardial infarction, as well as the risk of bioprosthetic valve failure after 8 years of follow-up. However, patients who underwent TAVI had a lower risk of structural valve deterioration compared to those who underwent SAVR.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems